Clinical Trials List
Protocol NumberEFC14660
2018-06-01 - 2020-12-31
Phase III
Terminated1
ICD-10E78.2
Mixed hyperlipidemia
ICD-10E78.0
Pure hypercholesterolemia
ICD-9272.2
Mixed hyperlipidemia
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Dau-Ming Niu Division of Pediatrics
- Wen-Chung Yu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
3 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
1 participants
-
Global
18 participants
